We have collected information about Immunoliposomes For The Targeted Delivery Of Antitumor Drugs for you. Follow the links to find out details on Immunoliposomes For The Targeted Delivery Of Antitumor Drugs.
https://www.sciencedirect.com/science/article/pii/S0169409X99000435
Immunoliposomes are an attractive carrier system for the delivery of lipophilic anticancer drugs or prodrugs to tumor cells. The liposomal bilayer may be exploited for incorporation of either lipophilic drugs or lipophilic derivatives (prodrugs) of hydrophilic drugs that are not efficiently retained in the aqueous phase of the liposome.Author: Enrico Mastrobattista, Gerben A Koning, Gerben A Koning, Gert Storm
https://www.sciencedirect.com/science/article/abs/pii/S0169409X99000435
First, problems that are encountered when immunoliposomes are used for systemic anticancer drug delivery and potential solutions are discussed. Second, an update is given of the in vivo results obtained with immunoliposomes in tumor models. Finally, new developments on the utilization of immunoliposomes for the treatment of cancer are highlighted.Author: Enrico Mastrobattista, Gerben A Koning, Gerben A Koning, Gert Storm
http://europepmc.org/abstract/MED/10837783
Dec 01, 1999 · Immunoliposomes for the targeted delivery of antitumor drugs. (PMID:10837783) Abstract Citations ; BioEntities ... problems that are encountered when immunoliposomes are used for systemic anticancer drug delivery and potential solutions are discussed. Second, an update is given of the in vivo results obtained with immunoliposomes in tumor models.Author: Enrico Mastrobattista, Gerben A Koning, Gerben A Koning, Gert Storm
https://www.rug.nl/research/portal/en/publications/immunoliposomes-for-the-targeted-delivery-of-antitumor-drugs(06c89cab-f87a-4904-869f-88db33c361c1).html
Immunoliposomes for the targeted delivery of antitumor drugs Mastrobattista, E., Koning, GA. & Storm, ... problems that are encountered when immunoliposomes are used for systemic anticancer drug delivery and potential solutions are discussed. Second, an update is given of the in vivo results obtained with immunoliposomes in tumor models.Author: Enrico Mastrobattista, Gerben A Koning, Gerben A Koning, Gert Storm
https://www.deepdyve.com/lp/elsevier/immunoliposomes-for-the-targeted-delivery-of-antitumor-drugs-Mxkabp2aa9
Read "Immunoliposomes for the targeted delivery of antitumor drugs, Advanced Drug Delivery Reviews" on DeepDyve, the largest online rental service for scholarly research with thousands of academic publications available at your fingertips.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526358/
Mastrobattista E, Koning GA, Storm G. Immunoliposomes for the targeted delivery of antitumor drugs. Adv Drug Deliv Rev. 1999; 40:103–27. Matsumura Y, Gotoh M, Muro K, et al. Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer. Ann Oncol.Author: Jörg Huwyler, Jürgen Drewe, Stephan Krähenbühl
https://www.ncbi.nlm.nih.gov/pubmed/19234988
Immunoliposomes were constructed with insulin, which was covalently linked to liposomes containing anticancer drugs. In order to investigate the targeting performance of insulin-modified immunoliposomes (SILs) in vivo, plasma pharmacokinetics, biodistribution, and antitumor activity were tested.Author: Zhiwen Yang, Muhua Yang, Guolun Xiahou, Jinnian Peng, Jian Zhang
https://www.researchgate.net/publication/329242663_Liposomes_as_target_delivery_of_antitumor_drugs
Request PDF Liposomes as target delivery of antitumor drugs Target delivery of antitumor drugs to cancer cells seems to be the very promising way of cancer therapy. The study on the ...
Searching for Immunoliposomes For The Targeted Delivery Of Antitumor Drugs?
You can just click the links above. The data is collected for you.
